Navigation Links
Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome
Date:1/15/2014

ed by an additional four weeks of open label treatment, the results of which are not yet available.  The trial enrolled 17 patients with genetically confirmed PWS, including 11 women and 6 men, with a mean age of 33.9 years, and mean body mass index (BMI) of 31.4 kg/m2.  Beloranib appeared to be safe and very well-tolerated.  All 17 patients completed the randomized treatment part of the trial and all opted to continue into and completed the four-week open label extension.

About Prader-Willi Syndrome
Prader-Willi syndrome (PWS), the most common known genetic cause of life-threatening obesity, causes constant hunger that drives PWS patients to gain more weight on fewer calories than the average person.  As a result, many of those affected become morbidly obese before the age of five.  There is currently no cure for this disease.  Although the cause is complex, it results from a deletion or loss of function of a cluster of genes on the 15th chromosome.  PWS typically causes low muscle mass and function, short stature, incomplete sexual development, and a chronic feeling of hunger that, coupled with a metabolism that utilizes drastically fewer calories than normal, can lead to excessive eating and life-threatening obesity.  PWS occurs in males and females equally and in all races, with the same incidence around the world.  Prevalence estimates have ranged from 1:8,000 to 1:50,000 with the most likely figure being approximately 1:40,000.  To the best of our knowledge, prevalence is about 5,000-7,000 people in the United States needing treatment.  You can learn more through the Prader-Willi Syndrome Association website at www.pwsausa.org.

About Beloranib
Beloranib is the first compound in its class that works by targeting a key enzyme called MetAP2 that controls the production and utilization of fatty acids.  Inh
'/>"/>

SOURCE Zafgen, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Zafgen Announces Initiation of Phase 2a Clinical Development with Beloranib in Obesity
2. Zafgen Secures $21 Million in Series D Financing
3. Zafgen Announces New Weight Loss and Safety Data from Phase 2 Study of Beloranib in Obesity at Obesity Week 2013
4. Zafgen Secures $45 Million in Series E Financing
5. Zafgen Appoints Chief Commercial Officer and New Member of Board of Directors
6. Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes
7. Young Innovations, Inc. Announces Record Sales and EPS for the Quarter Ended March 31, 2012
8. JDRF Announces Research Collaboration with Dexcom, Inc. to Develop "Smart Transmitter" Technology to Accelerate Artificial Pancreas Studies
9. Misonix Announces New Distribution Agreement For Panama
10. University of Maryland BioPark Announces MedImmunes Dr. Bahija Jallal as Newest Member of Board of Directors for UM Health Sciences Research Park
11. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... 3, 2015 Un fournisseur ... que sont l,hypertension, le diabète et les troubles ... éducatives gratuites et d,une conférence majeure dédiée à ... ) , Les formations ... Prendre en charge l,hypertension en ligne ...
(Date:7/2/2015)... -- Pharma Major Lupin Limited anunció ... ZAO "Biocom" en Rusia bajo ciertas condiciones de ... en el mercado farmacéutico de Rusia que registró ... uno de los 10 principales mercados farmacéuticos del ... una década, el mercado farmacéutico ruso registró un ...
(Date:7/2/2015)... N.C. , July 2, 2015  New product ... of its leading role in educating thought leaders about ... that can heavily influence how well a new therapy ... new study from research and consulting leader Best Practices, ... leaders need to focus on are early stage thought ...
Breaking Medicine Technology:Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 2Lutter contre trois maladies chroniques majeures en Amérique latine grâce à la formation médicale 3Lupin adquiere Biocom en Rusia 2Lupin adquiere Biocom en Rusia 3Medical Affairs Role in Thought Leader Education is Key Success Factor for New Product Launches in the Pharmaceutical Industry 2
... Not for release, publication or distribution, in whole or in ... where to do so would constitute a violation of the relevant laws ... BY ALERE AS HOLDINGS LIMITED ("ALERE AS HOLDINGS" OR ... FOR AXIS-SHIELD PLC ("AXIS-SHIELD" OR THE ...
... MIAMI and ATLANTA, Sept. 26, 2011 ASTRO Booth ... Oncology (ASTRO) 53rd Annual Meeting, October 2-6 in Miami ... solutions designed to simplify the complex processes involved in ... Elekta technology. "Radiotherapy techniques are becoming ...
Cached Medicine Technology:Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 2Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 3Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 4Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 5Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 6Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 7Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 8Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 9Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 10Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 11Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 12Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 13Alere Inc. Statement Amending Acceptance Condition to Axis-Shield Offer 14Elekta to Demonstrate How its Solutions Foster Confidence in Cancer Management at ASTRO Meeting in Miami 2Elekta to Demonstrate How its Solutions Foster Confidence in Cancer Management at ASTRO Meeting in Miami 3
(Date:7/3/2015)... ... ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, ... and expose popular lies regarding proper relationships according to the bible. , ... the core of the subject by explaining why certain types of sexual relationships are ...
(Date:7/2/2015)... ... ... Enterprises, LLC. is pleased to announce the opening of its newest location in Dallas, Texas. ... premium frozen yogurt chain was listed as #22 on the Inc. 500 list of fastest ... Bachman Lake, is located at:, 3701 W. Northwest Highway, STE 430, Dallas, TX 75220 , ...
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker Parking Consultants specified ... of Minnesota, they knew it would save the university energy and maintenance costs. ... the total energy savings after installation was an impressive 89 percent, which resulted ...
(Date:7/2/2015)... ... July 02, 2015 , ... “ LIFX ” was featured on NewsWatch ... products available to consumers. Amanda Forstrom, a technology expert and special reporter for NewsWatch, ... versatile smart light bulbs on the market. , According to the U.S. Department of ...
(Date:7/2/2015)... ... July 02, 2015 , ... Six months ahead of his 80th birthday, Don ... awareness and money for the Pulmonary Hypertension Association (PHA). Stevenson began the walk ... Washington, D.C. by mid-September. He left Glasgow, Mont. yesterday morning and is making his ...
Breaking Medicine News(10 mins):Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:sweetFrog Opens 18th Location in the Lone Star State 2Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3
... HealthDay Reporter , WEDNESDAY, March 23 (HealthDay News) -- ... unborn babies, Americans, level of exposure to mercury from ... higher risk of heart disease, stroke or other cardiovascular ... prior research that produced inconsistent results, scientists from Harvard ...
... 23 (HealthDay News) -- Exposure to high levels of ... death in lung transplant patients, a new study suggests. ... transplant patients over a five-year period, and found that ... bronchiolitis obliterans syndrome. Of those patients, 61 died. ...
... By Ellin Holohan HealthDay Reporter , WEDNESDAY, ... think they weigh less than they do, and many mothers ... research finds. The study of women and children conducted ... that faulty body image was far more prevalent among the ...
... March 23 (HealthDay News) -- The risk of lung cancer ... that of those who prefer regular cigarettes, researchers report. ... Administration advisory panel that made headlines Friday when it said ... While the panel concluded that menthols, minty flavor seems to ...
... MSc, an assistant professor of medicine at Boston University ... General Internal Medicine,s (SGIM) New England Region 2011 Clinician ... research. The award was presented to Rose at the ... SGIM works to promote research and education that ...
... Why salad helps you say yes to NO , ... the developed world, and can lead to heart attacks, strokes ... bypass surgery and angioplasty, themselves induce vascular injury, after which ... way that limits blood flow. Nitric oxide (NO) is an ...
Cached Medicine News:Health News:Americans' Exposure to Mercury From Fish Won't Harm Hearts: Study 2Health News:Americans' Exposure to Mercury From Fish Won't Harm Hearts: Study 3Health News:High Smog Levels Might Threaten Lung Transplant Success 2Health News:Many Obese Moms and Kids Underestimate Their Weight 2Health News:Many Obese Moms and Kids Underestimate Their Weight 3Health News:Menthol Cigarettes Pose No Added Lung Cancer Risk: Study 2Health News:JCI online early table of contents: March 23, 2011 2Health News:JCI online early table of contents: March 23, 2011 3Health News:JCI online early table of contents: March 23, 2011 4Health News:JCI online early table of contents: March 23, 2011 5Health News:JCI online early table of contents: March 23, 2011 6Health News:JCI online early table of contents: March 23, 2011 7Health News:JCI online early table of contents: March 23, 2011 8Health News:JCI online early table of contents: March 23, 2011 9Health News:JCI online early table of contents: March 23, 2011 10
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: